Published: 18 August 2020
Author(s): Alexander T. Cohen, Ulrich Hoffmann, Philippe Hainaut, Sean Gaine, Cihan Ay, Michiel Coppens, Marc Schindewolf, David Jimenez, Bernd Brüggenjürgen, Pierre Levy, Petra Laeis, Eva-Maria Fronk, Wolfgang Zierhut, Thomas Malzer, Marius Constantin Manu, Paul-Egbert Reimitz, Peter Bramlage, Giancarlo Agnelli, ETNA-VTE-Europe investigators
Section: Original article
Venous thromboembolism (VTE) encompasses both deep vein thrombosis (DVT) and pulmonary embolism (PE). It has an incidence of approximately 1–2 per 1,000 person-years in Europe [1]. While both events increase the probability of subsequent recurrent VTE [2], case fatality is higher after PE than after DVT [3–5].
